Batifiban TFA, a cyclic peptide and antagonist of the platelet glycoprotein GPIIb/IIIa, inhibits platelet aggregation by blocking the binding of circulating vitronectin to integrin alphanybeta3 [1].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
